aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8335
+0.0252 (3.12%)
Mar 23, 2026, 3:17 PM EDT - Market open
aTyr Pharma Employees
As of December 31, 2025, aTyr Pharma had 60 total employees, including 58 full-time and 2 part-time employees. The number of employees increased by 1 or 1.69% compared to the previous year.
Employees
60
Change (1Y)
1
Growth (1Y)
1.69%
Revenue / Employee
$3,167
Profits / Employee
-$1,235,300
Market Cap
81.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 60 | 1 | 1.69% | 58 | 2 |
| Dec 31, 2024 | 59 | 0 | - | 56 | 3 |
| Dec 31, 2023 | 59 | -11 | -15.71% | 56 | 3 |
| Dec 31, 2022 | 70 | 17 | 32.08% | 65 | 5 |
| Dec 31, 2021 | 53 | 10 | 23.26% | 49 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Seres Therapeutics | 103 |
| PolyPid | 73 |
| PMV Pharmaceuticals | 54 |
| Biomea Fusion | 42 |
| Vivani Medical | 37 |
| MediciNova | 13 |
ATYR News
- 17 days ago - aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - GlobeNewsWire
- 24 days ago - Ethos to Participate in The Citizens Technology Conference - GlobeNewsWire
- 25 days ago - Ethos Technologies Inc. (LIFE) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 6 weeks ago - The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. - Barrons